| 摘要 |
Specifically glycosylated insulins and pharmaceutical preparations hereof are provided. The novel insulins will preferably be mono-, di- or triglycosylated and contain a monosaccharide group or an oligosaccharide group with two or three sugar units. The specifically glycosylated insulins will have a high solubility and a more rapid onset of insulin action than for instance human insulin. |
